YARROW BIOSCIENCE, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
YARROW BIOSCIENCE, INC. (YARW) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $6.70 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2020-03-03
- YARROW BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-12-31 was $3.11M.
- YARROW BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-09-30 was $1.50M, a 51.21% increase year-over-year.
- YARROW BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-06-30 was $1.07M, a 43.16% increase year-over-year.
- YARROW BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-03-31 was $1.02M, a 23.97% increase year-over-year.
- YARROW BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2019 was $6.70M, a 84.19% increase from fiscal 2018.
- YARROW BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2018 was $3.64M, a 150.55% increase from fiscal 2017.
- YARROW BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2017 was $1.45M, a 153.40% increase from fiscal 2016.
- YARROW BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2016 was $573.00K, a 781.54% increase from fiscal 2015.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2019-12-31 | $3.11M derived: 10-K 12 month − 3 quarters · filed 2020-03-03 | $4.61M derived: sum of 2 quarters · filed 2020-03-03 | $5.68M derived: sum of 3 quarters · filed 2020-03-03 | $6.70M 10-K · filed 2020-03-03 |
| 2019-09-30 | $1.50M 10-Q · filed 2019-10-31 | $2.57M derived: sum of 2 quarters · filed 2019-10-31 | $3.59M derived: sum of 3 quarters · filed 2019-10-31 | |
| 2019-06-30 | $1.07M 10-Q · filed 2019-10-31 | $2.09M 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | $1.02M 10-Q · filed 2019-10-31 | |||
| 2018-12-31 | $3.64M 10-K · filed 2020-03-03 | |||
| 2018-09-30 | $994.00K 10-Q · filed 2019-10-31 | $1.74M derived: sum of 2 quarters · filed 2019-10-31 | $2.56M derived: sum of 3 quarters · filed 2019-10-31 | |
| 2018-06-30 | $746.00K 10-Q · filed 2019-10-31 | $1.57M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $822.00K 10-Q · filed 2019-10-31 | |||
| 2017-12-31 | $1.45M 10-K · filed 2020-03-03 | |||
| 2016-12-31 | $573.00K 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $65.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |